Enzymatically induced mineralization of platelet‐rich fibrin
Source abstract
Abstract
Abstract Membranes of the autologous blood‐derived biomaterial platelet‐rich fibrin (PRF) were functionalized by incorporation of alkaline phosphatase (ALP), an enzyme involved in mineralization of bone, and subsequently incubated in calcium glycerophosphate (CaGP) solution to induce PRFs mineralization with calcium phosphate (CaP) to improve PRFs suitability as a material for bone replacement. Incorporated ALP retained its bioactivity and induced formation of CaP material within PRF membranes, as confirmed by SEM, EDS, FTIR, and von Kossa staining. The mass percentage attributable to CaP was quantified by lyophilization and measurement of the remaining mass fraction as well as by TGA. Cytocompatibility tests (LDH, MTT, and WST) with SAOS‐2 cells showed that mineralized PRF did not release substances detrimental to cell vitality. Live/dead staining and SEM showed that mineralized PRF was colonized by cells. The results show that hydrogel biomaterials such as PRF can be mineralized through functionalization with ALP. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 2012.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Periodontal Regeneration and Treatments · Hemostasis and retained surgical items · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. 10.1016/j.tripleo.2005.07.01210.1016/j.tripleo.2005.07.012 ↗
2. Relevance of Choukroun's platelet‐rich fibrin (PRF) and SMAS flap in primary reconstruction after superficial or subtotal parotidectomy in patients with focal pleiomorphic adenoma: A new technique
3. 10.1902/jop.2009.09025210.1902/jop.2009.090252 ↗
4. 10.1097/ID.0b013e31819b5e3f10.1097/ID.0b013e31819b5e3f ↗
5. 10.1097/ID.0b013e318198cf0010.1097/ID.0b013e318198cf00 ↗
6. [The relevance of Choukroun's Platelet‐Rich Fibrin (PRF) during middle ear surgery: Preliminary results]
7. 10.1016/j.tripleo.2009.10.03810.1016/j.tripleo.2009.10.038 ↗
8. 10.1016/j.tripleo.2005.07.00810.1016/j.tripleo.2005.07.008 ↗
9. 10.1080/0897719080263671310.1080/08977190802636713 ↗
10. 10.1016/j.tripleo.2009.06.04410.1016/j.tripleo.2009.06.044 ↗
11. [Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: A new opportunity in facial lipostructure (Coleman's technique) and tympanoplasty?]
12. 10.1016/j.tripleo.2009.04.02010.1016/j.tripleo.2009.04.020 ↗
13. 10.1016/j.archoralbio.2010.01.00410.1016/j.archoralbio.2010.01.004 ↗
14. 10.1152/ajpcell.67.200810.1152/ajpcell.67.2008 ↗
15. 10.22203/eCM.v018a0110.22203/eCM.v018a01 ↗
16. 10.22203/eCM.v006a0310.22203/eCM.v006a03 ↗
17. 10.1007/s10856-007-3206-310.1007/s10856-007-3206-3 ↗
18. 10.1016/S8756-3282(01)00634-210.1016/S8756-3282(01)00634-2 ↗
19. 10.1163/15685620074405710.1163/156856200744057 ↗
20. [In vitro study of the effect of bisphosphonates on mineralization induced by a composite material: Poly 2(hydroxyethyl) methacrylate coupled with alkaline phosphatase]
21. 10.1172/JCI11580510.1172/JCI115805 ↗
22. 10.1016/j.biomaterials.2003.12.05710.1016/j.biomaterials.2003.12.057 ↗
23. 10.1002/adma.20080224210.1002/adma.200802242 ↗
24. 10.1016/8756-3282(90)90061-310.1016/8756-3282(90)90061-3 ↗
25. 10.1089/ten.tea.2010.032710.1089/ten.tea.2010.0327 ↗
26. 10.1073/pnas.78.12.731410.1073/pnas.78.12.7314 ↗
27. 10.1016/0006-291X(89)92729-010.1016/0006-291X(89)92729-0 ↗
28. 10.1002/jbmr.565005010910.1002/jbmr.5650050109 ↗
29. 10.1111/j.1600-0501.2009.01900.x10.1111/j.1600-0501.2009.01900.x ↗
30. 10.1016/j.tripleo.2009.02.00710.1016/j.tripleo.2009.02.007 ↗
31. 10.1016/j.biomaterials.2009.08.00110.1016/j.biomaterials.2009.08.001 ↗
32. 10.1016/j.biomaterials.2010.01.12810.1016/j.biomaterials.2010.01.128 ↗
33. 10.1021/bm801197m10.1021/bm801197m ↗
34. 10.1111/j.1600-0501.2009.01818.x10.1111/j.1600-0501.2009.01818.x ↗
35. 10.1007/s10856-009-3756-710.1007/s10856-009-3756-7 ↗
36. 10.1111/j.1600-0501.2009.01709.x10.1111/j.1600-0501.2009.01709.x ↗
37. 10.1089/ten.tec.2008.028810.1089/ten.tec.2008.0288 ↗
38. 10.1002/jbm.1028010.1002/jbm.10280 ↗
39. 10.1272/jnms.77.410.1272/jnms.77.4 ↗
40. 10.1016/j.actbio.2009.03.01910.1016/j.actbio.2009.03.019 ↗
41. 10.1016/j.biomaterials.2007.04.03110.1016/j.biomaterials.2007.04.031 ↗
42. 10.1016/j.biomaterials.2009.05.02210.1016/j.biomaterials.2009.05.022 ↗
43. 10.1007/s10856-005-6443-310.1007/s10856-005-6443-3 ↗
44. 10.1007/s10856-006-0086-x10.1007/s10856-006-0086-x ↗
45. 10.22203/eCM.v008a0110.22203/eCM.v008a01 ↗
46. 10.1007/s00402-004-0748-410.1007/s00402-004-0748-4 ↗
47. 10.1111/j.1600-0501.2009.01738.x10.1111/j.1600-0501.2009.01738.x ↗
48. 10.1016/j.biomaterials.2005.11.03810.1016/j.biomaterials.2005.11.038 ↗
49. 10.1126/science.92919410.1126/science.929194 ↗
50. 10.1002/(SICI)1097-4636(199605)31:1<43::AID-JBM6>3.0.CO;2-Q10.1002/(SICI)1097-4636(199605)31:1<43::AID-JBM6>3.0.CO;2-Q ↗
51. 10.1016/S0167-577X(00)00176-210.1016/S0167-577X(00)00176-2 ↗
52. 10.1016/j.actbio.2009.07.03810.1016/j.actbio.2009.07.038 ↗
53. 10.1093/emboj/16.2.30610.1093/emboj/16.2.306 ↗
54. 10.1016/S0009-8981(01)00584-810.1016/S0009-8981(01)00584-8 ↗
55. Time‐dependent changes in bone, placental, intestinal, and hepatic alkaline phosphatase activities in serum during human pregnancy10.1093/clinchem/33.10.1801 ↗
56. 10.1016/j.tripleo.2009.02.00410.1016/j.tripleo.2009.02.004 ↗